These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 11527416

  • 21. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
    Bae-Jump V, Segreti EM, Vandermolen D, Kauma S.
    Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
    [Abstract] [Full Text] [Related]

  • 22. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
    Kim CH, Moon SK, Bae JH, Lee JH, Han JH, Kim K, Choi EC.
    Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
    [Abstract] [Full Text] [Related]

  • 23. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
    Lasagna N, Fantappiè O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, Ziche M, Mazzanti R.
    Cancer Res; 2006 Mar 01; 66(5):2673-82. PubMed ID: 16510587
    [Abstract] [Full Text] [Related]

  • 24. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells.
    Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H.
    Cancer Gene Ther; 1996 Mar 01; 3(6):393-404. PubMed ID: 8988842
    [Abstract] [Full Text] [Related]

  • 25. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R.
    Clin Cancer Res; 2002 Feb 01; 8(2):620-7. PubMed ID: 11839685
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
    Heideman DA, Overmeer RM, van Beusechem VW, Lamers WH, Hakvoort TB, Snijders PJ, Craanen ME, Offerhaus GJ, Meijer CJ, Gerritsen WR.
    Cancer Gene Ther; 2005 Dec 01; 12(12):954-62. PubMed ID: 15905856
    [Abstract] [Full Text] [Related]

  • 27. Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines.
    Kamiyama T, Une Y, Uchino J, Hamada J.
    Int J Oncol; 1998 Mar 01; 12(3):655-9. PubMed ID: 9472107
    [Abstract] [Full Text] [Related]

  • 28. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
    Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S.
    Int J Oncol; 2007 Aug 01; 31(2):451-60. PubMed ID: 17611703
    [Abstract] [Full Text] [Related]

  • 29. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH.
    Chem Biol Interact; 2006 Mar 25; 160(2):123-33. PubMed ID: 16458870
    [Abstract] [Full Text] [Related]

  • 30. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK.
    J Pathol; 2009 Aug 25; 218(4):520-9. PubMed ID: 19431154
    [Abstract] [Full Text] [Related]

  • 31. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
    Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E.
    Hepatology; 1997 Mar 25; 25(3):619-23. PubMed ID: 9049208
    [Abstract] [Full Text] [Related]

  • 32. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A, Götze T, Korc M.
    Cancer Res; 2007 Nov 01; 67(21):10309-16. PubMed ID: 17974973
    [Abstract] [Full Text] [Related]

  • 33. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
    Watanabe T, Tsuda M, Makino Y, Ichihara S, Sawa H, Minami A, Mochizuki N, Nagashima K, Tanaka S.
    Mol Cancer Res; 2006 Jul 01; 4(7):499-510. PubMed ID: 16849525
    [Abstract] [Full Text] [Related]

  • 34. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY, Chen B, Zhan YQ, Xu WX, Li CY, Yang RF, Zheng H, Yue PB, Larsen SH, Sun HB, Yang X.
    J Hepatol; 2004 Aug 01; 41(2):267-73. PubMed ID: 15288476
    [Abstract] [Full Text] [Related]

  • 35. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.
    To C, Seiden I, Liu N, Wigle D, Tsao MS.
    Exp Cell Res; 2002 Feb 01; 273(1):45-53. PubMed ID: 11795945
    [Abstract] [Full Text] [Related]

  • 36. Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2.
    Tacchini L, Dansi P, Matteucci E, Desiderio MA.
    Exp Cell Res; 2000 Apr 10; 256(1):272-81. PubMed ID: 10739674
    [Abstract] [Full Text] [Related]

  • 37. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H, Hung W, Tremblay E, Wojcik J, Gui J, Ho J, Klassen J, Campling B, Elliott B.
    J Cell Biochem; 2002 Apr 10; 86(4):665-77. PubMed ID: 12210733
    [Abstract] [Full Text] [Related]

  • 38. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K, Ichinose S, Koike R, Kubota T, Yamaguchi M, Miyasaka M, Aso T.
    Gynecol Oncol; 2001 Nov 10; 83(2):205-15. PubMed ID: 11606073
    [Abstract] [Full Text] [Related]

  • 39. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.
    Cheng JC, Chou CH, Kuo ML, Hsieh CY.
    Oncogene; 2006 Nov 09; 25(53):7009-18. PubMed ID: 16732316
    [Abstract] [Full Text] [Related]

  • 40. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
    Tan S, Li R, Ding K, Lobie PE, Zhu T.
    FEBS Lett; 2011 Jul 21; 585(14):2229-34. PubMed ID: 21658389
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.